| ECM | Extracellular matrix |
| GAGs | Glycosaminoglycans |
| dn-Col | Denatured collagen |
| CBD | Collagen binding domain |
| MMP | Matrix metalloproteinase |
| MI | Myocardial infarction |
| DS | Dermatan sulfate |
| vWF | von Willeband’s factor |
| TIMP | Tissue inhibitors of metalloproteinase |
| CHP | Collagen hybridizing peptide |
| CMP | Collagen mimetic peptide |
| MAP | Mussel adhesive protein |
| NP | Nanoparticles |
| bFGF | Basic fibroblast growth factor |
| VEGF | Vascular endothelial growth factor |
| MK2 | Mitogen-activated protein kinase activated protein kinase 2 |
| SDF-1α | Stromal cell-derived factor-1α |
| QK | VEGF mimetic peptide |
| Sub P | Substance P |
| EGF | Epidermal growth factor |
| EGFR | Epidermal growth factor receptor |
| PEGDA | Poly(ethylene glycol) diacrylate |
| PV | Poly(vinyl alcohol) |
| PEODA | Poly(ethylene oxide) diacrylate |
| PLGA | Poly(lactide-co-glycolide) |
| MSC | Mesenchymal stromal cell |
| pMV-GLuc | Portal-mesenteric vein glucose |